The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

After a drug has passed through IND, the company files a new drug application (NDA) with FDA. A typical NDA filing must contain all the scientific information a company has compiled and commonly ...

A new report ... a certain drug interaction is not present or expected. As the field of membrane transporter research is evolving rapidly, transporter-specific information in NDA submissions ...

Oct. 09, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class ... of its Investigational New Drug (IND) application ...

over 200 investigational new drug (IND) applications covering botanical drugs are currently pending, although very few have made it to the NDA stage (S. Chen, FDA, personal communication).

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

As is customary, the Company must state the risk factor that the path to typical ... to US Food and Drug Administration. IND application refers to "Investigational New Drug" application.

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...